Newswise — Natural honey-bee products such as propolis, royal jelly, caffeic acid, honey and venom may have applications in cancer treatment and prevention, say Croatian researchers in Journal of the Science of Food and Agriculture this month.
Nada Orsolic and colleagues from the University of Zagreb found that bee products significantly decreased tumour growth and / or spreading (metastasis) in mice when they were applied orally or by injection.
The researchers tested both the preventative and curative effects of the bee products on tumour models in mice. In the prevention studies, the products were administered before inoculation with the tumour cells. In the curative studies, the products were administered after tumour inoculation.
"The effects of the tested compounds were demonstrated either by inhibition of tumour growth or metastases (secondary tumour) formation and by increased survival of the animals," said Dr Orsolic.
Propolis or caffeic acid significantly reduced subcutaneous tumour growth and prolonged the survival of mice. Honey also inhibited the spread of the tumour when applied before tumour cell inoculation in the lungs. Simultaneous inoculation with royal jelly and tumour cells significantly inhibited tumour spread. When bee venom was injected intratumourally, tumour shrinkage occurred, and the delay of tumour growth was evident. Survival of bee venom-treated mice was prolonged compared to control mice.
The way in which the bee products work to combat the tumours is not clear, but the authors suggest the chemicals cause apoptosis (cell suicide) or necrosis of the cancerous cells, or that they exert directly toxic or immunomodulatory effects. They may also reduce harmful oxyradicals in cells or body fluids.
The authors conclude that the intake of honey-bee products could be advantageous in the prevention and treatment of cancer.
"These results suggest the benefits of potential clinical trials using propolis or honey, combined with chemotherapeutic agents," said Dr Orsolic.
Honey-bee products in prevention and / or therapy of murine transplantable tumoursNada Orsolic, Svjetlana Terzic, Lidija Sver and Ivan BasicJournal of the Science of Food and Agriculture (available online 3rd December 2004).
About Journal of the Science of Food and AgricultureJournal of the Science of Food and Agriculture (JSFA) publishes peer-reviewed original research and critical reviews in these areas, with particular emphasis on interdisciplinary studies at the agriculture/food interface. This international journal covers fundamental and applied research.
JSFA is an SCI journal, published by John Wiley & Sons, on behalf of the Society of Chemical Industry, and is available in print (ISSN: 0022-5142) and online (ISSN: 1097-0010) via Wiley InterScience http://www.interscience.wiley.com. For further information about the journal go to http://interscience.wiley.com/jsfa
About SCISCI is a unique international forum where science meets business on independent, impartial ground. Anyone can join, and the Society offers a chance to share information between sectors as diverse as food and agriculture, pharmaceuticals, biotechnology, environmental science and safety. As well as publishing new research and running events, SCI has a growing database of member specialists who can give background information on a wide range of scientific issues. Originally established in 1881, SCI is a registered charity with members in over 70 countries.
About WileyJohn Wiley & Sons, Ltd., based in Chichester, England, is the largest subsidiary of John Wiley & Sons, Inc. Founded in 1807, John Wiley & Sons, Inc., provides must-have content and services to customers worldwide. Their core businesses include scientific, technical, and medical journals, encyclopedias, books, and online products and services; professional and consumer books and subscription services; and educational materials for undergraduate and graduate students and lifelong learners. Wiley has publishing, marketing, and distribution centres in the United States, Canada, Europe, Asia, and Australia. The company is listed on the New York Stock Exchange under the symbols JWa and JWb. Wiley's recently re-launched Internet site can be accessed at http://www.wileyeurope.com
If you would prefer not to receive further emails about our services and events, please reply to this email.
The information in this message is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorised. If you are not the intended recipient, any disclosure, copying, distribution or any action taken or, omitted to be taken, in reliance on it, is prohibited and may be unlawful. Any attachment(s) to this message has been checked for viruses, but please rely on your own virus checker and procedures.